Halozyme Therapeutics (NASDAQ:HALO) reported its Q4 earnings results on Tuesday, February 20, 2024 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

Halozyme Therapeutics missed estimated earnings by 1.2%, reporting an EPS of $0.82 versus an estimate of $0.83.

Revenue was up $48.54 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 10.04% increase in the share price the next day.

Here's a look at Halozyme Therapeutics's past performance:

To track all earnings releases for Halozyme Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.